Nucleic Acid Therapeutics Market Opportunities Enhanced by RNA-Targeted Therapeutics and Genome Editing

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Nucleic Acid Therapeutics Market - (By Technology (RNA targeted therapeutics, Gene Therapies, Epigenetic and microRNA modulating therapies, Genome editing therapies, Others), By Application (Autoimmune Disorders, Genetic Disorders, Infectious Diseases, Cancer, Others), By End User (Hospitals & Clinics, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Nucleic Acid Therapeutics Market is valued at US$ 4.93 billion in 2023, and it is expected to reach US$ 13.86 billion by 2031, with a CAGR of 13.8% during the forecast period of 2024-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2548

Nucleic acid therapeutics constitute a rapidly advancing segment of contemporary medicine, leveraging DNA- and RNA-based molecules to prevent, treat, and manage a wide spectrum of diseases. The market is expected to witness significant growth, fueled by intensified research and development efforts aimed at enhancing global healthcare capabilities in response to the rising prevalence of chronic illnesses and genetic disorders. Progress in biological therapeutics and DNA-driven interventions, alongside growing demand for innovative pharmaceutical solutions and improved healthcare services, further supports market expansion.

However, the sector faces several challenges. High treatment costs, a limited pool of professionals skilled in molecular biology and gene-editing technologies, and inadequate infrastructure in certain regions continue to restrict market accessibility. Nonetheless, the increasing focus on personalized medicine-which tailors therapies to individual genetic profiles-is promoting broader adoption of nucleic acid-based treatments. Moreover, growing investments by leading pharmaceutical and biotechnology companies in RNA- and DNA-based drug development, combined with accelerated clinical implementation and rising global healthcare demands, are anticipated to sustain market growth and advance the long-term commercialization of nucleic acid therapeutics.

List of Prominent Players in the Nucleic Acid Therapeutics Market:
• Novartis
• Moderna Inc
• BioNTech
• Arrowhead Pharmaceuticals
• Merck
• Thermo Fischer Scientific
• Sanofi
• Alnylam Pharmaceuticals
• Sarepta Therapeutics
• Qiagen
• Imugene
• Copernicus Therapeutics Inc.
• Protagonist Therapeutics
• Arbutus Biopharma
• Agilent Technologies
• Silence Therapeutics (UK),
• Astellas Pharma Inc. (Japan),
• CureVac SE (Germany),
• Sirnaomics (US),
• Arcturus Therapeutics Inc. (US)
• Other Market Players

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-03

Market Dynamics
Drivers:
The global nucleic acid therapeutics market is witnessing robust growth, largely driven by the rising prevalence of genetic disorders, including cystic fibrosis, muscular dystrophy, and various cancers, which present substantial treatment challenges. Significant investments from pharmaceutical corporations, governmental bodies, and academic research institutions are accelerating the discovery and development of novel therapies within this sector. Furthermore, favorable government policies that support pharmaceutical innovation have streamlined regulatory pathways and created an enabling business environment for market participants. Collectively, these factors are bolstering the expansion of the nucleic acid therapeutics market and are expected to sustain its growth over the forecast period.

Challenges:
Despite strong growth prospects, the nucleic acid therapeutics market faces several constraints. High research, development, and manufacturing costs continue to limit patient accessibility and affordability. The complex nature of nucleic acid-based therapies introduces technological challenges related to delivery mechanisms, molecular stability, and large-scale production. Additionally, stringent regulatory requirements and extended approval timelines may delay the introduction of new products. Limited awareness and understanding of these therapies among healthcare professionals and patients further restrict adoption, presenting ongoing barriers to broader market penetration.

Regional Trends:
North America is anticipated to maintain a leading position in the nucleic acid therapeutics market, supported by a strong compound annual growth rate (CAGR) over the forecast period. This leadership is driven by the high prevalence of chronic and genetic diseases, increasing demand for targeted and personalized treatment approaches, and substantial government funding for advanced medical research. Europe also represents a key regional market, underpinned by growing R&D investments that advance gene therapy applications and meet rising healthcare needs. Additional factors, including higher disposable incomes, expanding populations, and continuous enhancements in healthcare infrastructure, are expected to reinforce market growth across both regions.

Recent Developments:
• In April 2024, Arrowhead Pharmaceuticals, Inc. announced the dosing of its investigational RNA interference (RNAi) therapeutic, ARO-CFB, in a Phase 1/2a clinical trial. The trial included up to sixty-six healthy volunteers and patients with complement-mediated kidney disease.
• In Aug 2022, Merck and Orna Therapeutics entered into a collaboration agreement to jointly explore, create, and market various initiatives, such as vaccines and treatments, in the fields of infectious disease and oncology.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2548

Segmentation of Nucleic Acid Therapeutics Market-
By Technology-
• RNA Targeted Therapeutics
• Gene Therapies
• Epigenetic and microRNA Modulating Therapies
• Genome Editing Therapies
• Others
By Application-
• Autoimmune Disorders
• Genetic Disorders
• Infectious Diseases
• Cancer
• Others
By End-User-
• Hospitals & Clinics
• Academic & Research Institutes
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/nucleic-acid-therapeutics-market/2548

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.